Journal Title：Hematological Oncology

Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:

-Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders

-Diagnostic investigations, including imaging and laboratory assays

-Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases

-Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies

-Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.

Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.

《血液腫瘤學》雜志刊登的文章涉及造血和淋巴系統(tǒng)腫瘤疾病的實驗和臨床方面以及相關事宜。特別歡迎將基礎科學應用于臨床問題的轉化研究。鼓勵投稿涉及以下領域的稿件：

-血液腫瘤的臨床實踐和管理，包括：急性和慢性白血病、惡性淋巴瘤、骨髓增生性疾病

-診斷研究，包括影像學和實驗室檢測

-血液疾病的血液腫瘤的流行病學、病理學和病理生物學

-治療問題，包括 1、2 或 3 期試驗以及同種異體和自體干細胞移植研究

-正?；蚧疾≡煅土馨图毎募毎飳W、分子生物學、分子遺傳學和細胞遺傳學方面，包括干細胞和細胞因子以及其他調節(jié)系統(tǒng)。

歡迎簡明扼要、主題鮮明的綜述材料，尤其是如果它能讓更廣泛的社區(qū)能夠接觸到新的概念和想法?？梢耘c主編討論評論材料的提案。只有具有更廣泛的科學或臨床相關性的病例材料和病例報告集合才會被考慮。

Hematological Oncology創(chuàng)刊于1983年，由John Wiley and Sons Ltd出版商出版，收稿方向涵蓋血液學 - 醫(yī)學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業(yè)影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 12周，或約稿 ，影響因子指數(shù)3.3，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。